Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...

One of the more popular stocks in the pharmaceutical sector of late got the cold shoulder from investors on Tuesday. Eli Lilly (NYSE: LLY) closed today's trading session down by almost 6% in value, ...

(Reuters) -Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than ...

Novo, which became Europe’s most valuable listed company following the launch of Wegovy in 2021, is now facing a reckoning as ...

* Researchers at the Danish Headache Center are testing semaglutide along with a very low calorie diet as a treatment for new ...

Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Comedian and Emmy-nominated actor Kym Whitley opens up about her long journey with weight management. The "Happy Gilmore 2" ...

Texas hairstylist Tim Bo Mack opened up to PEOPLE about his years-long struggle to lose weight. He finally found success ...

Weight-loss wonder drug Mounjaro/Zepbound shrinks breast cancer tumors Date: July 15, 2025 Source: The Endocrine Society Summary: A cutting-edge mouse study reveals that tirzepatide, the dual GLP ...

SAN FRANCISCO — Concurrent use of menopausal hormone therapy may augment the weight loss benefits of tirzepatide for postmenopausal women with overweight or obesity, researchers reported at ...

A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others. Should you?